日本のワクチン市場レポート：製品タイプ、治療タイプ、技術、投与経路、患者タイプ、適応症、流通チャネル、エンドユーザー、地域別、2025年～2033年

日本のワクチンの市場規模は2024年に30億米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに39億米ドルに達し、2025～2033年の成長率（CAGR）は2.88％になると予測しています。いくつかの慢性疾患の有病率の上昇、広範な医療保険の利用可能性の増加、ワクチン接種の重要性に関する大衆の意識の高まりは、市場を牽引する主な要因のいくつかです。

本レポートで扱う主な質問

• 日本のワクチン市場はこれまでどのように推移し、今後どのように推移するのか？
• COVID-19が日本のワクチン市場に与えた影響は？
• 日本のワクチン市場の製品タイプ別区分は？
• 日本のワクチン市場の治療タイプ別区分は？
• 日本のワクチン市場の技術別の区分は？
• 日本のワクチン市場の投与経路別の区分は？
• 日本のワクチン市場の患者タイプ別の区分は？
• 日本のワクチン市場の適応症別の区分は？
• 日本のワクチン市場の流通チャネル別の区分は？
• 日本のワクチン市場のエンドユーザー別の区分は？
• 日本のワクチン市場のバリューチェーンにおける様々なステージとは？
• 日本のワクチンの主な促進要因と課題は何か？
• 日本のワクチン市場の構造と主要プレーヤーは？
• 日本のワクチン市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
• 市場推定
• 調査手法

第3章 エグゼクティブサマリー

第4章 日本のワクチン市場- イントロダクション

• 概要
• 市場力学
• 業界動向
• 競合情報

第5章 日本のワクチン市場情勢

• 過去および現在の市場動向（2019～2024年）
• 市場予測（2025～2033年）

第6章 日本のワクチン市場- 製品タイプ別の内訳

• 多価ワクチン
• 一価ワクチン

第7章 日本のワクチン市場- 治療タイプ別の内訳

• 予防ワクチン
• 治療ワクチン

第8章 日本のワクチン市場- 技術別の内訳

• 結合ワクチン
• 不活化ワクチンとサブユニットワクチン
• 生弱毒化ワクチン
• 組み換えワクチン
• トキソイドワクチン
• その他

第9章 日本のワクチン市場- 投与経路別の内訳

• 筋肉内および皮下投与
• 経口投与
• その他

第10章 日本のワクチン市場- 患者タイプ別の内訳

• 小児
• 成人

第11章 日本のワクチン市場- 適応症別の内訳

• 細菌性疾患
• ウイルス性疾患

第12章 日本のワクチン市場- 流通チャネル別の内訳

• 病院薬局
• 小売薬局
• 機関投資家向け販売
• その他

第13章 日本のワクチン市場- エンドユーザー別の内訳

• 病院
• クリニック
• ワクチン接種センター
• 学術研究機関
• その他

第14章 日本のワクチン市場- 競合情勢

• 概要
• 市場構造
• 市場企業のポジショニング
• 主要成功戦略
• 競合ダッシュボード
• 企業評価象限

第15章 主要企業のプロファイル

第16章 日本のワクチン市場- 業界分析

• 促進要因、抑制要因、機会
• ポーターのファイブフォース分析
• バリューチェーン分析

第17章 付録

Japan vaccine market size reached USD 3.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.9 Billion by 2033, exhibiting a growth rate (CAGR) of 2.88% during 2025-2033. The rising prevalence of several chronic diseases, increasing availability of extensive health insurance coverage, and the growing awareness among the masses about the importance of vaccination represent some of the key factors driving the market.

A vaccine is a biological preparation that contains weakened or inactivated forms of pathogens or their components. It is administered to stimulate the immune system and provide immunity against specific diseases. It is rigorously tested for safety to ensure it does not pose significant risks to recipients. It is available in various forms, which include live attenuated, inactivated, subunit, mRNA, and viral vector vaccines. It requires strict temperature control during storage and transportation to maintain efficacy. It is highly effective in preventing a wide range of infectious diseases and often more cost-effective than treating the diseases. It is routinely administered to infants and children to protect them from diseases like measles, mumps, rubella, and pertussis.

Japan Vaccine Market Trends:

The expanding aging population in Japan represents one of the primary factors catalyzing the demand for vaccines to protect against age-related diseases. Additionally, the rising prevalence of several chronic diseases and the growing awareness among the masses about the importance of vaccination are offering a favorable market outlook in the country. Along with this, the country has a well-established distribution network that aids in ensuring vaccines reach the entire population. Apart from this, the increasing participation of Japan in vaccine diplomacy initiatives is bolstering its international standing and creating opportunities for vaccine manufacturers, enhancing production and exports. Furthermore, the expansion of pediatric vaccination programs with a focus on ensuring children receive recommended vaccines is strengthening the growth of the market. Moreover, continuous investments in research and development (R&D) efforts in the field of vaccines are stimulating the market growth. Along with this, rising collaborations with international organizations are facilitating access to a wide range of vaccines and contributing to market growth. Apart from this, the introduction of robust patient education campaigns is disseminating vital information about the benefits of vaccines, further improving acceptance rates. In addition, the availability of extensive health insurance coverage is ensuring the affordability of vaccines for the majority of the population. In addition, the emergence of Japan as a healthcare tourism destination is attracting visitors seeking healthcare services, including vaccinations. Furthermore, the robust epidemiological surveillance systems in Japan facilitate the identification of disease outbreaks and vaccination needs promptly, ensuring a swift response and heightened vaccine demand. Moreover, the expansion of domestic vaccine manufacturing capacity in Japan is ensuring a more self-reliant and resilient supply chain, reducing dependence on imports. Along with this, governing authorities of the country are implementing various incentives and streamlining regulatory processes to encourage vaccine development and manufacturing. These initiatives reduce the barriers to entry for vaccine manufacturers, fostering innovation and competition in the market.

Japan Vaccine Market Segmentation:

Product Type Insights:

• Multivalent Vaccine
• Monovalent Vaccine

Treatment Type Insights:

• Preventive Vaccine
• Therapeutic Vaccine

Technology Insights:

• Conjugate Vaccines
• Inactivated and Subunit Vaccines
• Live Attenuated Vaccines
• Recombinant Vaccines
• Toxoid Vaccines
• Others

Route of Administration Insights:

• Intramuscular and Subcutaneous Administration
• Oral Administration
• Others

Patient Type Insights:

• Pediatric
• Adult

Indication Insights:

• Bacterial Diseases
  • Meningococcal Disease
  • Pneumococcal Disease
  • Diphtheria/Tetanus/Pertussis (DPT)
  • Tuberculosis
  • Haemophilus Influenzae (Hib)
  • Typhoid
  • Others
• Viral Diseases
  • Hepatitis
  • Influenza
  • Human Papillomavirus (HPV)
  • Measles/Mumps/Rubella (MMR)
  • Rotavirus
  • Herpes Zoster
  • Varicella
  • Japanese Encephalitis
  • Rubella
  • Polio
  • Rabies
  • Dengue
  • Others

Distribution Channel Insights:

• Hospital Pharmacies
• Retail Pharmacies
• Institutional Sales
• Others

End User Insights:

• Hospitals
• Clinics
• Vaccination Centers
• Academic and Research Institutes
• Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan vaccine market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan vaccine market?
• What is the breakup of the Japan vaccine market on the basis of product type?
• What is the breakup of the Japan vaccine market on the basis of treatment type?
• What is the breakup of the Japan vaccine market on the basis of technology?
• What is the breakup of the Japan vaccine market on the basis of route of administration?
• What is the breakup of the Japan vaccine market on the basis of patient type?
• What is the breakup of the Japan vaccine market on the basis of indication?
• What is the breakup of the Japan vaccine market on the basis of distribution channel?
• What is the breakup of the Japan vaccine market on the basis of end user?
• What are the various stages in the value chain of the Japan vaccine market?
• What are the key driving factors and challenges in the Japan vaccine?
• What is the structure of the Japan vaccine market and who are the key players?
• What is the degree of competition in the Japan vaccine market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Vaccine Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Vaccine Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Vaccine Market - Breakup by Product Type

• 6.1 Multivalent Vaccine
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Forecast (2025-2033)
• 6.2 Monovalent Vaccine
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)

7 Japan Vaccine Market - Breakup by Treatment Type

• 7.1 Preventive Vaccine
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Therapeutic Vaccine
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)

8 Japan Vaccine Market - Breakup by Technology

• 8.1 Conjugate Vaccines
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Inactivated and Subunit Vaccines
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Live Attenuated Vaccines
  • 8.3.1 Overview
  • 8.3.2 Historical and Current Market Trends (2019-2024)
  • 8.3.3 Market Forecast (2025-2033)
• 8.4 Recombinant Vaccines
  • 8.4.1 Overview
  • 8.4.2 Historical and Current Market Trends (2019-2024)
  • 8.4.3 Market Forecast (2025-2033)
• 8.5 Toxoid Vaccines
  • 8.5.1 Overview
  • 8.5.2 Historical and Current Market Trends (2019-2024)
  • 8.5.3 Market Forecast (2025-2033)
• 8.6 Others
  • 8.6.1 Historical and Current Market Trends (2019-2024)
  • 8.6.2 Market Forecast (2025-2033)

9 Japan Vaccine Market - Breakup by Route of Administration

• 9.1 Intramuscular and Subcutaneous Administration
  • 9.1.1 Overview
  • 9.1.2 Historical and Current Market Trends (2019-2024)
  • 9.1.3 Market Forecast (2025-2033)
• 9.2 Oral Administration
  • 9.2.1 Overview
  • 9.2.2 Historical and Current Market Trends (2019-2024)
  • 9.2.3 Market Forecast (2025-2033)
• 9.3 Others
  • 9.3.1 Historical and Current Market Trends (2019-2024)
  • 9.3.2 Market Forecast (2025-2033)

10 Japan Vaccine Market - Breakup by Patient Type

• 10.1 Pediatric
  • 10.1.1 Overview
  • 10.1.2 Historical and Current Market Trends (2019-2024)
  • 10.1.3 Market Forecast (2025-2033)
• 10.2 Adult
  • 10.2.1 Overview
  • 10.2.2 Historical and Current Market Trends (2019-2024)
  • 10.2.3 Market Forecast (2025-2033)

11 Japan Vaccine Market - Breakup by Indication

• 11.1 Bacterial Diseases
  • 11.1.1 Overview
  • 11.1.2 Historical and Current Market Trends (2019-2024)
  • 11.1.3 Market Segmentation
    • 11.1.3.1 Meningococcal Disease
    • 11.1.3.2 Pneumococcal Disease
    • 11.1.3.3 Diphtheria/Tetanus/Pertussis (DPT)
    • 11.1.3.4 Tuberculosis
    • 11.1.3.5 Haemophilus Influenzae (Hib)
    • 11.1.3.6 Typhoid
    • 11.1.3.7 Others
  • 11.1.4 Market Forecast (2025-2033)
• 11.2 Viral Diseases
  • 11.2.1 Overview
  • 11.2.2 Historical and Current Market Trends (2019-2024)
  • 11.2.3 Market Segmentation
    • 11.2.3.1 Hepatitis
    • 11.2.3.2 Influenza
    • 11.2.3.3 Human Papillomavirus (HPV)
    • 11.2.3.4 Measles/Mumps/Rubella (MMR)
    • 11.2.3.5 Rotavirus
    • 11.2.3.6 Herpes Zoster
    • 11.2.3.7 Varicella
    • 11.2.3.8 Japanese Encephalitis
    • 11.2.3.9 Rubella
    • 11.2.3.10 Polio
    • 11.2.3.11 Rabies
    • 11.2.3.12 Dengue
    • 11.2.3.13 Others
  • 11.2.4 Market Forecast (2025-2033)

12 Japan Vaccine Market - Breakup by Distribution Channel

• 12.1 Hospital Pharmacies
  • 12.1.1 Overview
  • 12.1.2 Historical and Current Market Trends (2019-2024)
  • 12.1.3 Market Forecast (2025-2033)
• 12.2 Retail Pharmacies
  • 12.2.1 Overview
  • 12.2.2 Historical and Current Market Trends (2019-2024)
  • 12.2.3 Market Forecast (2025-2033)
• 12.3 Institutional Sale
  • 12.3.1 Overview
  • 12.3.2 Historical and Current Market Trends (2019-2024)
  • 12.3.3 Market Forecast (2025-2033)
• 12.4 Others
  • 12.4.1 Overview
  • 12.4.2 Historical and Current Market Trends (2019-2024)
  • 12.4.3 Market Forecast (2025-2033)

13 Japan Vaccine Market - Breakup by End User

• 13.1 Hospitals
  • 13.1.1 Overview
  • 13.1.2 Historical and Current Market Trends (2019-2024)
  • 13.1.3 Market Forecast (2025-2033)
• 13.2 Clinics
  • 13.2.1 Overview
  • 13.2.2 Historical and Current Market Trends (2019-2024)
  • 13.2.3 Market Forecast (2025-2033)
• 13.3 Vaccination Centers
  • 13.3.1 Overview
  • 13.3.2 Historical and Current Market Trends (2019-2024)
  • 13.3.3 Market Forecast (2025-2033)
• 13.4 Academic and Research Institutes
  • 13.4.1 Overview
  • 13.4.2 Historical and Current Market Trends (2019-2024)
  • 13.4.3 Market Forecast (2025-2033)
• 13.5 Others
  • 13.5.1 Historical and Current Market Trends (2019-2024)
  • 13.5.2 Market Forecast (2025-2033)

14 Japan Vaccine Market - Competitive Landscape

• 14.1 Overview
• 14.2 Market Structure
• 14.3 Market Player Positioning
• 14.4 Top Winning Strategies
• 14.5 Competitive Dashboard
• 14.6 Company Evaluation Quadrant

15 Profiles of Key Players

• 15.1 Company A
  • 15.1.1 Business Overview
  • 15.1.2 Product Portfolio
  • 15.1.3 Business Strategies
  • 15.1.4 SWOT Analysis
  • 15.1.5 Major News and Events
• 15.2 Company B
  • 15.2.1 Business Overview
  • 15.2.2 Product Portfolio
  • 15.2.3 Business Strategies
  • 15.2.4 SWOT Analysis
  • 15.2.5 Major News and Events
• 15.3 Company C
  • 15.3.1 Business Overview
  • 15.3.2 Product Portfolio
  • 15.3.3 Business Strategies
  • 15.3.4 SWOT Analysis
  • 15.3.5 Major News and Events
• 15.4 Company D
  • 15.4.1 Business Overview
  • 15.4.2 Product Portfolio
  • 15.4.3 Business Strategies
  • 15.4.4 SWOT Analysis
  • 15.4.5 Major News and Events
• 15.5 Company E
  • 15.5.1 Business Overview
  • 15.5.2 Product Portfolio
  • 15.5.3 Business Strategies
  • 15.5.4 SWOT Analysis
  • 15.5.5 Major News and Events

16 Japan Vaccine Market - Industry Analysis

• 16.1 Drivers, Restraints and Opportunities
  • 16.1.1 Overview
  • 16.1.2 Drivers
  • 16.1.3 Restraints
  • 16.1.4 Opportunities
• 16.2 Porters Five Forces Analysis
  • 16.2.1 Overview
  • 16.2.2 Bargaining Power of Buyers
  • 16.2.3 Bargaining Power of Suppliers
  • 16.2.4 Degree of Competition
  • 16.2.5 Threat of New Entrants
  • 16.2.6 Threat of Substitutes
• 16.3 Value Chain Analysis

17 Appendix